PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8674891-6	1996	Insulin resistance decreased by using antihypertensive treatments with bunazosin, cilazapril, amlodipine, and benidipine in hypertensive subjects.	Cilazapril	82-92	insulin	Homo sapiens	0-7	
11797459-0	2001	[Effect of cilazapril on insulin sensitivity in patients with essential arterial hypertension].	Cilazapril	11-21	insulin	Homo sapiens	25-32	
11797459-8	2001	After a 12-week cilazapril treatment insulin sensitivity significantly increased, while glucose efficacy was relatively unchanged.	Cilazapril	16-26	insulin	Homo sapiens	37-44	
9240771-8	1996	Reduction of blood pressure with alpha blocker (bunazosin), ACE inhibitor (cilazapril), long-acting Ca++ blocker (amlodipine) significantly improved lowered insulin sensitivity.	Cilazapril	75-85	insulin	Homo sapiens	157-164	
8563700-7	1995	Cilazapril treatment has beneficial effect in the reversal of insulin resistance in patients with essential hypertension.	Cilazapril	0-10	insulin	Homo sapiens	62-69	
8563700-0	1995	Normalization of insulin resistance in non-obese essential hypertension by cilazapril treatment.	Cilazapril	75-85	insulin	Homo sapiens	17-24	
8628189-0	1995	[The effect of cilazapril and prazosin on insulin sensitivity in patients with essential hypertension].	Cilazapril	15-25	insulin	Homo sapiens	42-49	
8628189-2	1995	The objective of this study was to examine short-term effects of cilazapril and prazosin therapy on insulin sensitivity assessed by a 15" test of insulin tolerance of obese hypertensive persons.	Cilazapril	65-75	insulin	Homo sapiens	100-107	
1388960-8	1992	Plasma glucose and insulin responses decreased by 8 +/- 3% (P less than .05) and 25 +/- 9% (P less than .002), respectively, in cilazapril-treated patients, but did not change in those treated with cilazapril plus HC.	Cilazapril	128-138	insulin	Homo sapiens	19-26